Effects of inhaled nitric oxide on hemostasis in healthy adults treated with heparin: a randomized, controlled, blinded crossover study

Table 2 Patient Demographics

Patient*	Treatment Sequence	Age	Height (cm)	Weight (kg)
001	HPP/PNP/PPA/HNP	34	181	77.9
002	HNP/PPA/PNP/HPP	28	170	74.4
003	PNP/HNP/HPP/PPA	46	181	93.9
004	PPA/HPP/HNP/PNP	23	179	64.7
005	HPP/PNP/PPA/HNP	49	179	84.3
006	PNP/HNP/HPP/PPA	47	176	82.5
007	PPA/HPP/HNP/PNP	26	181	88.4
008	HNP/PPA/PNP/HPP	41	193	104.3
009	HNP/PPA/PNP/HPP	48	175	70.9
010	HPP/PNP/PPA/HNP	20	180	69.7
011	PNP/HNP/HPP/PPA	19	170	67.7
012	PPA/HPP/HNP/PNP	22	184	84.1

*All patients were white males.
HNP, heparin injection + nitric oxide inhalation + placebo capsules; HPP, heparin injection + placebo inhalation + placebo capsules; PNP, placebo injection + nitric oxide inhalation + placebo capsules; PPA, placebo injection + placebo inhalation + aspirin capsules.

ISSN: 1477-9560